J., Hsieh, Y
Diabetes Obes Metab Seferovi PM, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T, Bauersachs J, Anker SD, Ray R, avuolu Y, Polovina M, Metra M, Ambrosio G, Prasad K, Seferovi J, Jhund PS, Dattilo G, elutkiene J, Piepoli M, Moura B, Chioncel O, Ben Gal T, Heymans S, de Boer RA, Jaarsma T, Hill L, Lopatin Y, Lyon AR, Ponikowski P, Lainak M, Jankowska E, Mueller C, Cosentino F, Lund L, Filippatos GS, Ruschitzka F, Coats AJS, Rosano GMC (2020) Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control
Or stick to the dosage prescribed by your treating doctor based on your condition
In individuals with intact AVP system, GLP-1 RA treatment is thought to reduce AVP secretion and induce natriuresis, increasing fluid delivery to the distal nephron and collecting ducts